LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | -20.0% | 29,636 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -50.0% | 29,636 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -70.6% | 29,636 | 0.0% | 0.00% | – |
| Q4 2021 | $68,000 | -49.6% | 29,636 | 0.0% | 0.00% | – |
| Q3 2021 | $135,000 | +3.1% | 29,636 | 0.0% | 0.00% | – |
| Q2 2021 | $131,000 | -89.8% | 29,636 | -83.3% | 0.00% | – |
| Q1 2021 | $1,289,000 | -7.3% | 177,029 | -2.8% | 0.00% | – |
| Q4 2020 | $1,390,000 | +13.3% | 182,136 | +34.8% | 0.00% | – |
| Q3 2020 | $1,227,000 | +2.9% | 135,078 | -4.1% | 0.00% | – |
| Q2 2020 | $1,192,000 | +138.9% | 140,847 | +39.5% | 0.00% | – |
| Q1 2020 | $499,000 | -19.0% | 100,977 | +18.0% | 0.00% | – |
| Q4 2019 | $616,000 | -33.7% | 85,602 | -0.4% | 0.00% | – |
| Q3 2019 | $929,000 | -19.6% | 85,925 | -3.3% | 0.00% | – |
| Q2 2019 | $1,156,000 | +33.0% | 88,889 | +1.1% | 0.00% | – |
| Q1 2019 | $869,000 | -0.5% | 87,951 | +4.7% | 0.00% | – |
| Q4 2018 | $873,000 | – | 83,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,466,783 | $69,906,000 | 1.33% |
| Board of Trustees of The Leland Stanford Junior University | 949,443 | $10,264,000 | 1.11% |
| Lion Point Capital, LP | 500,000 | $5,405,000 | 0.60% |
| Sio Capital Management, LLC | 122,536 | $1,325,000 | 0.43% |
| Redmile Group, LLC | 749,026 | $8,097,000 | 0.27% |
| SAMLYN CAPITAL, LLC | 639,977 | $6,918,000 | 0.17% |
| Stanley-Laman Group, Ltd. | 19,530 | $211,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,378,475 | $14,901,000 | 0.04% |
| FRANKLIN RESOURCES INC | 700,000 | $7,567,000 | 0.00% |
| Jefferies Group LLC | 10,618 | $115,000 | 0.00% |